Related Experiment Video
Updated: Jul 4, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1
Tracie L Miller1, E John Orav, Steven E Lipshultz
1Division of Pediatric Clinical Research, Department of Pediatrics, Miller School of Medicine, University of Miami, Miami, FL 33101, USA. tracie.miller@miami.edu
Insights
Children with human immunodeficiency virus (HIV) have poorer cardiovascular disease (CVD) risk profiles than their peers. Antiretroviral therapy significantly influences these cardiac risk factors in HIV-infected children.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Public Health
Background:
- Cardiovascular disease (CVD) is a growing concern in children.
- Understanding CVD risk factors in pediatric human immunodeficiency virus (HIV) infection is crucial for long-term health outcomes.
Purpose of the Study:
- To identify cardiovascular disease (CVD) risk factors in children with human immunodeficiency virus (HIV).
- To compare CVD risk profiles in HIV-infected children with a nationally representative control group.
Main Methods:
- Prospective, longitudinal analysis of 42 HIV-infected children.
- Comparison with controls from the 2003-2004 National Health and Nutrition Examination Survey (NHANES).
- Multivariable modeling of demographic, disease-specific, and treatment-related factors.
Main Results:
- HIV-infected children exhibited lower weight, height, and body mass index compared to controls.
- Elevated triglycerides and lower high-density lipoprotein (HDL) cholesterol levels were observed in the HIV cohort.
- Protease inhibitor therapy was linked to adverse lipid profiles, while nonnucleoside reverse-transcriptase inhibitor therapy showed associations with lower visceral fat and higher HDL cholesterol.
Conclusions:
- Children with HIV present with unfavorable cardiovascular risk profiles.
- Antiretroviral therapy plays a significant role in modulating these cardiac risk factors.
Objective:
To determine risk factors for cardiovascular disease (CVD) in children infected with human immunodeficiency virus (HIV) compared with nationally representative controls from 2003-2004 National Health and Nutrition Examination Survey (NHANES) data.
Study Design:
A prospective, longitudinal analysis of CVD risk factors in 42 HIV-infected children compared with NHANES controls, with multivariable modeling of demographic, disease-specific, and treatment-related factors contributing to cardiac risk in the HIV cohort.
Results:
The 42 children infected with HIV were initially an average of 10.1 years old; 68% were Centers for Disease Control and Prevention pediatric HIV disease stage B or C, and 76% were receiving highly active antiretroviral therapy (HAART). Compared with age- and sex-adjusted NHANES controls, the children infected with HIV had lower weight (-0.46 standard deviation [SD] vs +0.54 SD; P < .001), height (-0.62 SD vs +0.26 SD; P < .001), and body mass index (-0.09 SD vs +0.51 SD; P < .001), a higher level of triglycerides (136 mg/dL vs 90 mg/dL; P < .001), and a lower level of high-density lipoprotein (HDL) cholesterol (47 mg/dL vs 54 mg/dL; P < .001). Protease inhibitor therapy was independently associated with higher triglyceride (P = .02) and low-density lipoprotein cholesterol levels (P = .04) and lower HDL cholesterol level (P = .02); nonnucleoside reverse-transcriptase inhibitor therapy was associated with lower visceral fat (P = .01) and higher HDL cholesterol level (P = .005).
Conclusions:
Children infected with HIV have adverse cardiac risk profiles compared with NHANES controls. Antiretroviral therapy has a significant influence on these factors.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

